These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3463774)

  • 21. [Antibiotic susceptibility of the clinically isolated staphylococcal strains resistant to cephalosporin derivatives].
    Arai T
    Jpn J Antibiot; 1985 Feb; 38(2):199-202. PubMed ID: 3847517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of Mueller-Hinton broth on the in vitro activities of cefuzoname, flomoxef, imipenem, and minocycline against Staphylococcus aureus].
    Fujita S; Tonohata A
    Jpn J Antibiot; 1990 May; 43(5):757-60. PubMed ID: 2391746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fundamental and clinical studies on cefuzonam in the field of pediatrics].
    Kuno K; Hakamada S; Miyachi Y; Nakashima T; Hayakawa F; Miura K; Miyajima Y
    Jpn J Antibiot; 1987 Feb; 40(2):405-18. PubMed ID: 3599389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of eight antibiotics against methicillin-resistant S. aureus and S. epidermidis strains isolated in Korea.
    Chang WH; Choi MS; Chung HY; Seo WJ; Choi TY; Chong YS; Kim JS; Chung SS; Hong SH
    J Korean Med Sci; 1988 Jun; 3(2):45-50. PubMed ID: 3267354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of cephalosporins against coagulase-negative staphylococci.
    Chin NX; Neu NM; Neu HC
    Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
    Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Problem of the in vitro sensitivity to cefamandole of methicillin-resistant Staphylococcus aureus].
    de Rautlin de la Roy Y; Fanaud P; Grignon B
    Pathol Biol (Paris); 1985 Dec; 33(10):957-61. PubMed ID: 3912706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
    Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
    Frongillo RF; Bianchi P; Moretti A; Pasticci MB; Ripa S; Pauluzzi S
    Antimicrob Agents Chemother; 1984 May; 25(5):666-8. PubMed ID: 6563877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic susceptibility of bacteria isolated from surgical infections (first report)].
    Yura J; Shinagawa N; Ishikawa S; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T; Sakai K
    Jpn J Antibiot; 1986 Oct; 39(10):2557-78. PubMed ID: 3543430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 Feb; 49(2):194-202. PubMed ID: 8721079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible usefulness of cephem antibiotics with anti-staphylococcal activity for preventing the spread of methicillin-resistant Staphylococcus aureus.
    Hikida M; Mori M; Yoshida M; Yokota T
    Jpn J Antibiot; 1993 Sep; 46(9):836-9. PubMed ID: 8254903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of cefotiam against oxacillin-resistant Staphylococcus epidermidis strains--reevaluation of beta-lactam antibiotics efficiency on MRSE.
    Nakamura A; Oguri T; Misawa S; Tabe Y; Kondo S; Miyake K; Miyake N; Igari J; Ohsaka A
    Jpn J Antibiot; 2007 Jun; 60(3):153-60. PubMed ID: 17867489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. II. cefuzonam plus minocycline].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1992 Jun; 45(6):605-11. PubMed ID: 1507394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the in vitro activity of cephalothin and cefamandole on methillicin-resistant strains of Staphylococcus aureus and epidermidis].
    Bianchi P; Caroppo BG; Pasticci MB; Galuppo L; Frongillo RF
    Clin Ter; 1984 Feb; 108(4):283-9. PubMed ID: 6232064
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of in vitro activities of first, second and third generation cephem antibiotics against various pathogens isolated from clinical material in 1985].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1986 Oct; 39(10):2579-86. PubMed ID: 3100836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.